7 employees
Eternygen focuses on research and development of innovative drugs using a network of renowned scientists & contract research organizations.
2012
$8.4M
from 2 investors over 2 rounds
Eternygen GmbH raised $8.4M on January 9, 2017
Investors: Epidarex Capital and Evotec